Artelo Biosciences
ARTL
2 hedge funds and large institutions have $18K invested in Artelo Biosciences in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
20% more capital invested
Capital invested by funds: $15K → $18K (+$3K)
0% more funds holding
Funds holding: 2 → 2 (0)
0% more ownership
Funds ownership: 0% → 0% (0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Goldman Sachs
New York
| $17K | – | – | – |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $1K | +$1K | +3 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| – | -$1K | -3 | Closed |
|
ARTL Hedge Fund Activity: Q2 2020 in Review
2 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences (ARTL) for Q2 2020, worth a combined $18K — up 20% from $15K a quarter earlier.
Fund positioning in ARTL was balanced in Q2 2020: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $1K. The largest seller was UBS Group, exiting entirely with an estimated $1K sold.
- 2 institutional investors held Artelo Biosciences (ARTL) as of Q2 2020, unchanged from Q1 2020.
- Funds reported $18K of Artelo Biosciences stock for Q2 2020, up 20% quarter-over-quarter.
- 1 fund opened new Artelo Biosciences positions in Q2 2020 and 1 closed out, a net change of 0 holders.
- The largest Artelo Biosciences buyer in Q2 2020 was Tower Research Capital (TRC), an estimated $1K added.
- The largest Artelo Biosciences seller in Q2 2020 was UBS Group, an estimated $1K sold.
Based on aggregated 13F filings for Q2 2020.